Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.

Human gene therapy

Volumn 23, Issue 10, 2012, Pages 1043-1053

  Morgan, Richard A ^a   Johnson, Laura A ^b   Davis, Jeremy L ^b   Zheng, Zhili ^b   Woolard, Kevin D ^b   Reap, Elizabeth A ^b   Feldman, Steven A ^b   Chinnasamy, Nachimuthu ^b   Kuan, Chien Tsun ^b   Song, Hua ^b   Zhang, Wei ^b   Fine, Howard A ^b   Rosenberg, Steven A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR VIII; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; BIOLOGICAL THERAPY; BRAIN TUMOR; CANCER STEM CELL; CELL STRAIN 3T3; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENETICS; GLIOMA; HUMAN; IMMUNOLOGY; METHODOLOGY; MOUSE; PATHOLOGY; T LYMPHOCYTE; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CELL LINE, TUMOR; GENETIC ENGINEERING; GENETIC VECTORS; GLIOMA; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MICE; NEOPLASTIC STEM CELLS; NIH 3T3 CELLS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANTIGEN; T-LYMPHOCYTES; TISSUE THERAPY; TRANSDUCTION, GENETIC;

EID: 84875198775     PISSN: None     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.041     Document Type: Article

References (0)